Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Wound healing support" is a general, non-specific term referring to interventions or processes that aid the repair of tissue injury. Physiologically, wound healing progresses through four major overlapping phases: hemostasis (blood clotting), inflammation, proliferation (granulation tissue formation, angiogenesis, re-epithelialization), and remodeling (matrix reorganization and scar formation)[1][3][4][5][6]. Numerous cells (e.g., platelets, neutrophils, macrophages, keratinocytes, fibroblasts, endothelial cells) and signaling molecules (cytokines, growth factors, matrix proteins) cooperate in this process. There is no single molecule or receptor named "wound healing support," but rather an array of molecular targets may be modulated to support healing—such as inhibiting inflammation, enhancing growth factor signaling, or optimizing matrix remodeling[1][2][3][4][5][6]. Because it is a physiologic process and not a distinct molecular entity, it is incorrect to classify "wound healing support" as a therapeutic target, receptor, enzyme, transporter, or protein family member.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wound healing support.